Rocco DeVillers
Papers
1
Total Citations
56
H-Index
1
About
Rocco DeVillers is a leading neuro-oncology researcher whose work focuses on advancing treatment strategies for glioblastoma multiforme (GBM), particularly in the setting of local recurrence. His major contributions center on the integration of fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy, a combination that has shown significant promise in improving outcomes for patients with this aggressive brain tumor. His landmark 2014 prospective cohort study, which has garnered 56 citations, demonstrated both a meaningful response rate and acceptable toxicity profile for this salvage approach—a critical finding given the limited options available for recurrent GBM. This work has helped shape clinical protocols and sparked further investigation into radiosensitizing chemotherapy regimens. DeVillers’ research addresses one of the most pressing challenges in neuro-oncology: the management of local recurrence after standard therapy. His findings have been instrumental in providing evidence for a treatment strategy that balances efficacy with quality of life, making him a respected voice in the field. For students and researchers, his work exemplifies the rigorous translational research needed to tackle treatment-resistant brain cancers.
Research Focus
Key Achievements
Top Papers
- 1